Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	IDXXIdexx Laboratories	BDXBecton Dickinson	EWEdwards Lifesciences
Snapshot
Price	$545.73	$140.71	$85.88
Market cap	$44.34B	$39.67B	$50.30B
Valuation
P/E	40.5x	35x	45.8x
Forward P/E	32.3x	46.6x	65.5x
Growth
Revenue growth	13.1%	2.4%	13.8%
EPS growth	25.6%	-24.8%	-73.2%
Profitability
Net margin	24.6%	5.3%	17.4%
ROE	70.9%	4.5%	10.6%
Balance sheet & cash
Debt / equity	0.53x	0.76x	0.06x
Free cash flow yield	1.9%	9.0%	2.9%
Dividend yield	—	2.9%	—
Verdict
Investment rating	Favorable· 65	Weak· 37	Neutral· 47

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	IDXXtoday $546	BDXtoday $141	EWtoday $86
2027	$514.04 – $753.92+38% CAGR	$107.64 – $157.88+12% CAGR	$65.70 – $96.36+12% CAGR
2028	$645.58 – $946.85+32% CAGR	$109.80 – $161.03+7% CAGR	$67.01 – $98.28+7% CAGR
2029	$810.78 – $1,189.15+30% CAGR	$111.99 – $164.25+5% CAGR	$68.35 – $100.25+5% CAGR
2030	$1,018.26 – $1,493.45+29% CAGR	$114.23 – $167.54+4% CAGR	$69.72 – $102.26+4% CAGR
2031	$1,278.83 – $1,875.62+28% CAGR	$116.52 – $170.89+4% CAGR	$71.11 – $104.30+4% CAGR
5-yr CAGR	18.6% – 28.0%	-3.7% – 4.0%	-3.7% – 4.0%